IL6, can prevent dendritic cell maturation, prime tumor-specific T-cells via signal transducer and activator of transcription 3 (STAT3) signaling, inhibit NF-κB binding activity, and inhibit C-C chemokine receptor type 7 (CCR7) expression [45–47]. The gene discussed is NFKB1; the disease is neoplasm.